Y Murata

No ORCID on file · 4 papers in corpus
other 2006
The expression of fractalkine in the endometrium during the menstrual cycle
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2005.12.012

OBJECTIVE: The objective of the study was to evaluate the presence of fractalkine in the endometrium of the uterus and the change of fractalkine protein levels during menstrual cycle. METHODS: Twelve samples of endometrium of the uterus we…

other 2005
Fractalkine in the peritoneal fluid of women with endometriosis
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2005.06.018

OBJECTIVE: The objective of this study was to evaluate the presence of fractalkine in the ascites and the association between fractalkine levels in the ascites and endometriosis. METHODS: Peritoneal fluids and peripheral blood samples were…

observational 2000
Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis
Molecular human reproduction ·doi:10.1093/molehr/6.9.829

Secretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase. We investigated whether SLPI was present in the peritoneal fluid of women with endometriosis and to clarify the role of SLPI in the pathogenesi…

rct 2000
Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy ("draw-back" therapy)
Fertility and sterility ·doi:10.1016/s0015-0282(99)00636-6

OBJECTIVE: To evaluate the efficacy of half-dose GnRH agonist therapy for endometriosis. DESIGN: Prospective, longitudinal pilot study. SETTING: Osaka University Hospital. PATIENT(S): Patients with symptomatic endometriosis. INTERVENTIO…